United States · Bill · HR
H.R. 2005 (114th)
Medicare Drug Savings Act of 2015
Introduced
23 April 2015
Last action
13 May 2015 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Castor, Kathy [D-FL-14], Rep. Levin, Sander M. [D-MI-12], Rep. Cartwright, Matt [D-PA-17], Rep. Brown, Corrine [D-FL-5], Rep. Pocan, Mark [D-WI-2], Rep. Lee, Barbara [D-CA-12], Rep. Grijalva, Raúl M. [D-AZ-7], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Lowenthal, Alan S. [D-CA-47], Rep. Takano, Mark [D-CA-39], Rep. Titus, Dina [D-NV-1], Rep. DeSaulnier, Mark [D-CA-10], Rep. Edwards, Donna F. [D-MD-4], Rep. Honda, Michael M. [D-CA-15], Rep. Beyer, Donald S. [D-VA-8], Rep. Blumenauer, Earl [D-OR-3]
Subjects
Healthcare
Source updated
5 December 2025
Summary
Medicare Drug Savings Act of 2015 Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSAct) to require drug manufacturers to pay the Secretary of Health and Human Services drug rebates for rebate eligible (low-income) individuals. Excludes from Medicare coverage as a part D drug any drug or biological manufactured by a manufacturer that has not entered into and have in effect a rebate agreement with the Secretary. Requires a rebate agreement to require a drug or biological manufacturer to provide to the Secretary a rebate, determined according to a specified formula, for each rebate period ending after December 31, 2015, for any covered Medicare part D drug dispensed after that date to any rebate eligible individual for which payment was made by a prescription drug plan sponsor or MedicareAdvantage organization for such period. Specifies a formula for determination of Medicaid rebate amounts for such drugs or biologicals. Amends SSAct title XIX (Medicaid) to exclude any amounts paid under a rebate agreement from the determination of best price and average manufacturer price under the Medicaid program.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
23 April 2015
Introduced
Introduced in House
Source: IntroReferral
23 April 2015
Introduced
Introduced in House
Source: IntroReferral
23 April 2015
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
23 April 2015
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
24 April 2015
Referred
Referred to the Subcommittee on Health.
Source: Committee
13 May 2015
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 23 April 2015 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 23 April 2015
Introduced in House (PDF)
Introduced in House · EN · 23 April 2015
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 23 April 2015
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Castor, Kathy [D-FL-14] · D · Sponsor
- Rep. Levin, Sander M. [D-MI-12] · D · Sponsor
- Rep. Cartwright, Matt [D-PA-17] · D · Cosponsor
- Rep. Brown, Corrine [D-FL-5] · D · Cosponsor
- Rep. Pocan, Mark [D-WI-2] · D · Cosponsor
- Rep. Lee, Barbara [D-CA-12] · D · Cosponsor
- Rep. Grijalva, Raúl M. [D-AZ-7] · D · Cosponsor
- Rep. Schakowsky, Janice D. [D-IL-9] · D · Cosponsor
- Rep. Lowenthal, Alan S. [D-CA-47] · D · Cosponsor
- Rep. Takano, Mark [D-CA-39] · D · Cosponsor
- Rep. Titus, Dina [D-NV-1] · D · Cosponsor
- Rep. DeSaulnier, Mark [D-CA-10] · D · Cosponsor
- Rep. Edwards, Donna F. [D-MD-4] · D · Cosponsor
- Rep. Honda, Michael M. [D-CA-15] · D · Cosponsor
- Rep. Beyer, Donald S. [D-VA-8] · D · Cosponsor
- Rep. Blumenauer, Earl [D-OR-3] · D · Cosponsor
- · hswm00 · Standing
- · hsif00 · Standing
Related records
- related to → Medicare Drug Savings Act of 2015
- related to ← Prescription Drug Affordability Act of 2015
- related to ← Prescription Drug Affordability Act of 2015
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/114th-congress/house-bill/2005
- Open data entity: https://api.congress.gov/v3/bill/114/hr/2005
- us · 114-hr-2005 · source updated 5 December 2025